Swiss-based Salus Alpha Group, the vanguard of Ucits fund development since it was established in 2001, is attracting institutional investors in Asia, helped by the fact tPARA_BREAK_SENTINEL_9f8e7d6c

Swiss-based Salus Alpha Group, the vanguard of Ucits fund development since it was established in 2001, is attracting institutional investors in Asia, helped by the fact that it opened two new offices in Hong Kong and Singapore recently. As Asia’s appetite for newcits grows, Hedgeweek asked the group’s CEO, Oliver Prock (pictured), for his thoughts on the region. “There exists only one global brand in fund structures and that’s UCITS,” says Prock via email. “Investors have learned that even US mutual funds, due to the possibility of self-administration, can fail. Asian investors have clearly seen the advantage of UCITS funds.” Prock believes that whilst there exists an upward trend of Asian investors buying newcits for their safety, “there is also a clear trend of Asian promoters setting up UCITS funds with Asian exposure to be distributed in Europe.” Asked whether the forthcoming UCITS IV regulation will influence the firm’s product suite, Prock said: “The only trigger for changes I see for Salus Alpha’s product development is the master/feeder structure and I’m sure we will take advantage of this.”